VEGFA and wet macular degeneration: While anti-VEGF (anti-vascular endothelial growth factor) therapies have proven effective in managing wet AMD, treatment options for the dry form remain limited, highlighting a critical gap in current therapeutic strategies (Orozco et al., 2023).